According to a newly published market research report by 24LifeSciences, the global chronic ocular surface pain market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025–2032.
Chronic Ocular Surface Pain (COSP) is a complex and debilitating condition...
According to a newly published market research report by 24LifeSciences, the global chronic ocular surface pain market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025–2032.
Chronic Ocular Surface Pain (COSP) is a complex and debilitating condition...
According to a newly published market research report by 24LifeSciences, the global chronic ocular surface pain market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025–2032.
Chronic Ocular Surface Pain (COSP) is a complex and debilitating condition...
According to a newly published market research report by 24LifeSciences, the global predictive and presymptomatic testing market was valued at USD 5.8 billion in 2024 and is projected to reach USD 16.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.9% during the forecast period 20252032.
Predictive and presymptomatic testing involves the analysis of genetic,...
According to a newly published market research report by 24LifeSciences, the global predictive and presymptomatic testing market was valued at USD 5.8 billion in 2024 and is projected to reach USD 16.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.9% during the forecast period 20252032.
Predictive and presymptomatic testing involves the analysis of genetic,...
According to a newly published market research report by 24LifeSciences, the global predictive and presymptomatic testing market was valued at USD 5.8 billion in 2024 and is projected to reach USD 16.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.9% during the forecast period 20252032.
Predictive and presymptomatic testing involves the analysis of genetic,...
PRESS RELEASE
According to a newly published market research report by 24LifeSciences, global pectoral retractor market was valued at USD 937 million in 2024 and is projected to reach USD 1.49 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period.
A pectoral retractor is a specialized surgical instrument designed to provide optimal exposure of...
PRESS RELEASE
According to a newly published market research report by 24LifeSciences, global pectoral retractor market was valued at USD 937 million in 2024 and is projected to reach USD 1.49 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period.
A pectoral retractor is a specialized surgical instrument designed to provide optimal exposure of...
PRESS RELEASE
According to a newly published market research report by 24LifeSciences, global pectoral retractor market was valued at USD 937 million in 2024 and is projected to reach USD 1.49 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period.
A pectoral retractor is a specialized surgical instrument designed to provide optimal exposure of...
According to a newly published market research report by 24LifeSciences, global randomization and trial supply management market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.7% during the forecast period 20252032.
Randomization and Trial Supply Management (RTSM) refers to specialized clinical trial...
According to a newly published market research report by 24LifeSciences, global randomization and trial supply management market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.7% during the forecast period 20252032.
Randomization and Trial Supply Management (RTSM) refers to specialized clinical trial...
According to a newly published market research report by 24LifeSciences, global randomization and trial supply management market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.7% during the forecast period 20252032.
Randomization and Trial Supply Management (RTSM) refers to specialized clinical trial...
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek